Clin2
NCT06080620Likely a fitRecruiting

Choosing the best treatment for locally advanced breast cancer

Locally Advanced Breast Cancer

Treatments studied

Part of Cancer clinical trials.

This study looks at different treatment plans for women with newly diagnosed, locally advanced breast cancer (stage IIIb-IIIc). It aims to find the most effective combination of surgery, chemotherapy, and radiotherapy. If you are a woman aged 18-70 with this diagnosis and your tumor can be surgically removed, this trial may be an option for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 70 years old.
  • You have been newly diagnosed with locally advanced breast cancer (stage IIIb or IIIc).
  • A doctor thinks your tumor can be removed with surgery, based on ultrasound showing it's not wrapped around a major vein in your armpit.
  • You are willing to have surgery, chemotherapy, and radiation therapy as part of your treatment.
  • You are willing to complete questionnaires about your quality of life and emotional well-being for the study.
  • You have not had any previous breast cancer treatment (surgery, chemo, or radiation).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06499168Not yet recruiting
Predicting chemotherapy response in advanced breast cancer

This trial studies whether doctors can predict how well chemotherapy will work for women with locally advanced breast cancer before surgery. It may help match patients to more effective treatment.

NCT07376538Recruiting· Phase 2
Treating advanced breast cancer based on treatment response

This trial tests a personalized approach to treating breast cancer that has spread to nearby lymph nodes. Your surgery and radiation will be tailored to how well your cancer responds to initial chemotherapy or hormone therapy.

Beijing, Beijing Municipality
NCT06908668Recruiting· Phase 2
Adebrelimab plus chemo with or without radiation before breast cancer surgery

This trial tests adding a drug called adebrelimab to standard chemotherapy and possibly radiation, given before surgery for breast cancer that is HER2-negative and locally advanced. The goal is to see if this combination helps shrink tumors more effectively, potentially allowing for breast-conserving surgery.

Beijing
NCT07385365Not yet recruiting· Phase 3
Radiation after surgery for intermediate-risk breast cancer

This trial is testing whether giving radiation to nearby lymph nodes after surgery can help prevent breast cancer from coming back. It is for women with a specific type of breast cancer that has spread to a few lymph nodes but can be removed with surgery.

Beijing, Beijing Municipality
NCT05896865Recruiting
Personalized breast cancer radiation based on tumor biology

This trial studies whether adjusting radiation dose using how the tumor behaves can improve outcomes for people with locally advanced breast cancer that has spread to certain nearby lymph nodes. It may help deliver the right radiation intensity while avoiding unnecessary exposure.

Seoul
NCT06697938Recruiting
Chemo plus radiation vs. chemo alone for locally advanced breast cancer

This trial compares two treatments for locally advanced breast cancer: chemotherapy before surgery plus radiation, versus chemotherapy before surgery alone. The goal is to see which approach works better for this specific type of cancer.

Chengdu, Sichuan

Hear when a new Locally Advanced Breast Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.